This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Arch Capital Group (ACGL) Stock Moves -1.91%: What You Should Know
by Zacks Equity Research
In the latest trading session, Arch Capital Group (ACGL) closed at $89.23, marking a -1.91% move from the previous day.
Do Options Traders Know Something About Arch Capital Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to ACGL stock based on the movements in the options market lately.
Arch Capital Group (ACGL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Arch Capital Group (ACGL) closed the most recent trading day at $91.11, moving +1.04% from the previous trading session.
KNSL Lags Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Kinsale Capital is set to gain from a focus on the excess and supply market, prudent underwriting, lower expense ratio, solid investment portfolio and capital deployment.
ACGL Trading at a Premium to Industry: How Should You Play the Stock?
by Zacks Equity Research
Arch Capital is poised to gain from new business opportunities, increased exposures, a better renewal rate environment and effective capital deployment.
TRV Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Travelers' momentum in renewal rate improvements, high retention levels and increased new business are likely to sustain its earnings growth.
Is Arch Capital (ACGL) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Arch Capital (ACGL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AXS Outperforms Industry, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
AXIS Capital gains from a well-performing specialty insurance, reinsurance, as well as the accident and health portfolio.
NMIH Stock Near 52-Week High: A Signal for Investors to Hold Tight?
by Zacks Equity Research
NMI Holdings is well-positioned for growth, with higher new insurance written volume, a comprehensive reinsurance program and prudent capital deployment.
Chubb Stock Trades Above 200-Day SMA: What Should Investors Do?
by Zacks Equity Research
CB fuels growth with global middle-market expansion, strategic M&A, strong premiums, and a solid capital position despite catastrophe risk.
Arch Capital Group (ACGL) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Arch Capital Group (ACGL) closed at $89.78, marking a -2.78% move from the previous day.
Arch Capital Group (ACGL) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, Arch Capital Group (ACGL) stood at $94.75, denoting a -1.12% change from the preceding trading day.
Arch Capital (ACGL) Up 2.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Arch Capital (ACGL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AXS vs. ACGL: Which P&C Insurance Stock Should You Hold Now?
by Zacks Equity Research
Let's see how AXS and ACGL fare in terms of some of the key metrics.
CNA Financial Near 52-Week High: Time to Buy, Sell or Hold the Stock?
by Zacks Equity Research
CNA is poised to gain from solid retention, favorable renewal premium change and new business growth across Specialty, Commercial and International segments.
Implied Volatility Surging for Arch Capital Group Stock Options
by Zacks Equity Research
Investors need to pay close attention to ACGL stock based on the movements in the options market lately.
Arch Capital Trades Above 50-Day SMA: Time to Hold ACGL Stock?
by Zacks Equity Research
ACGL is poised to gain from new business opportunities, increased exposures, a better renewal rate environment and effective capital deployment.
RLI Trading at a Premium to Industry: How Should You Play the Stock?
by Zacks Equity Research
RLI stock is poised to gain from portfolio, business expansion, expanded distribution and operational strength, driving growth.
Top Research Reports for AMD, Union Pacific & Lowe's
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), Union Pacific Corporation (UNP) and Lowe's Companies, Inc. (LOW), as well a micro-cap stock Syntec Optics Holdings, Inc. (OPTX).
AXIS Capital Stock Near 52-Week High: Is This Your Buy Signal?
by Zacks Equity Research
AXS gains from a well-performing specialty insurance, reinsurance, as well as the accident and health portfolio.
LNC Stock Down Despite Q1 Earnings Beat on Long-Term Disability Results
by Zacks Equity Research
Lincoln National's Q1 results gain from solid insurance premiums and a well-performing Group Protection segment, partly offset by an elevated expense level.
WRB Stock Near 52-Week High: A Signal for Investors to Hold Tight?
by Zacks Equity Research
W.R. Berkley stock gains from higher premiums, lower claims frequency in certain lines of business, effective capital deployment and sufficient liquidity.
Investors Heavily Search Arch Capital Group Ltd. (ACGL): Here is What You Need to Know
by Zacks Equity Research
Arch Capital (ACGL) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AMSF Stock Down 6% Despite Q1 Earnings Beat on New Business Growth
by Zacks Equity Research
AMERISAFE's Q1 results reflect premium growth and fee income surge, partly offset by weaker underwriting profits and rising underwriting expenses.